Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Naulaerts

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Proteomics|November 29, 2014
Bioinformatics approaches for the functional interpretation of protein lists: from ontology term enrichment to network analysisKris Laukens, Stefan Naulaerts, Wim Vanden Berghe
Genes and Immunity|September 11, 2023
Reverse translation: the key to increasing the clinical success of immunotherapy?Isaure Vanmeerbeek, Stefan Naulaerts, Abhishek D Garg
Scientific Reports|June 21, 2017
Predicting the Reliability of Drug-target Interaction Predictions with Maximum Coverage of Target SpaceAntonio Peón, Stefan Naulaerts, Pedro J Ballester
Biomolecules|July 2, 2020
Concise Polygenic Models for Cancer-Specific Identification of Drug-Sensitive Tumors from Their Multi-Omics ProfilesStefan Naulaerts, Michael P Menden, Pedro J Ballester
Oncotarget|December 13, 2017
Precision and recall oncology: combining multiple gene mutations for improved identification of drug-sensitive tumoursStefan Naulaerts, Cuong C Dang, Pedro J Ballester
Frontiers in Chemistry|August 6, 2019
Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC DataPavel Sidorov, Stefan Naulaerts, Jérémy Ariey-Bonnet, et al.
Biomedicines|October 23, 2021
Predicting Cancer Drug Response In Vivo by Learning an Optimal Feature Selection of Tumour Molecular ProfilesLinh C Nguyen, Stefan Naulaerts, Alejandra Bruna, et al.
Journal of Virology|October 31, 2014
Varicella-zoster virus-derived major histocompatibility complex class I-restricted peptide affinity is a determining factor in the HLA risk profile for the development of postherpetic neuralgiaPieter Meysman, Benson Ogunjimi, Stefan Naulaerts, et al.
Nature|June 7, 2023
Tumour immune rejection triggered by activation of α2-adrenergic receptorsJingjing Zhu, Stefan Naulaerts, Loubna Boudhan, et al.
Immunological Reviews|November 8, 2023
The cell stress and immunity cycle in cancer: Toward next generation of cancer immunotherapyRaquel S Laureano, Isaure Vanmeerbeek, Jenny Sprooten, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Proteomics|November 29, 2014
Bioinformatics approaches for the functional interpretation of protein lists: from ontology term enrichment to network analysisKris Laukens, Stefan Naulaerts, Wim Vanden Berghe
Genes and Immunity|September 11, 2023
Reverse translation: the key to increasing the clinical success of immunotherapy?Isaure Vanmeerbeek, Stefan Naulaerts, Abhishek D Garg
Scientific Reports|June 21, 2017
Predicting the Reliability of Drug-target Interaction Predictions with Maximum Coverage of Target SpaceAntonio Peón, Stefan Naulaerts, Pedro J Ballester
Biomolecules|July 2, 2020
Concise Polygenic Models for Cancer-Specific Identification of Drug-Sensitive Tumors from Their Multi-Omics ProfilesStefan Naulaerts, Michael P Menden, Pedro J Ballester
Oncotarget|December 13, 2017
Precision and recall oncology: combining multiple gene mutations for improved identification of drug-sensitive tumoursStefan Naulaerts, Cuong C Dang, Pedro J Ballester
Frontiers in Chemistry|August 6, 2019
Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC DataPavel Sidorov, Stefan Naulaerts, Jérémy Ariey-Bonnet, et al.
Biomedicines|October 23, 2021
Predicting Cancer Drug Response In Vivo by Learning an Optimal Feature Selection of Tumour Molecular ProfilesLinh C Nguyen, Stefan Naulaerts, Alejandra Bruna, et al.
Journal of Virology|October 31, 2014
Varicella-zoster virus-derived major histocompatibility complex class I-restricted peptide affinity is a determining factor in the HLA risk profile for the development of postherpetic neuralgiaPieter Meysman, Benson Ogunjimi, Stefan Naulaerts, et al.
Nature|June 7, 2023
Tumour immune rejection triggered by activation of α2-adrenergic receptorsJingjing Zhu, Stefan Naulaerts, Loubna Boudhan, et al.
Immunological Reviews|November 8, 2023
The cell stress and immunity cycle in cancer: Toward next generation of cancer immunotherapyRaquel S Laureano, Isaure Vanmeerbeek, Jenny Sprooten, et al.
Pageof 4